European Commission approves Bavarian Nordic vaccine against monkeypox

Middle East
25-07-2022 | 08:02
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
European Commission approves Bavarian Nordic vaccine against monkeypox
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
0min
European Commission approves Bavarian Nordic vaccine against monkeypox
The European Commission has approved to broaden the use of the Danish pharma group Bavarian Nordic vaccine to battle monkeypox, according to the firm.

The European Medicines Authority (EMA) authorized the use of the Imvanex vaccine against monkeypox on Friday, despite the fact that it has been approved in the European Union against human smallpox since 2013.
 

Breaking Headlines

Vaccine

Europe

Monkeypox

Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More